MaxPro Medical
MaxPro Medical
As a cornerstone of In-Vitro Diagnostics (IVD), urine analysis has evolved from simple chemical strip reading to complex morphological analysis. Modern Urine Analyzers are vital for the early detection of renal diseases, diabetes, and metabolic disorders. In the global landscape, China has emerged as a hub for high-precision medical manufacturing, combining cost-efficiency with cutting-edge AI integration.
The global urine analyzer market is projected to reach billions by 2030, driven by an aging population and the rise of chronic diseases. Suppliers from China, particularly leaders like Shenzhen MaxPro Medical, are bridging the gap between clinical-grade accuracy and point-of-care (POC) accessibility, serving markets from North America to Southeast Asia.
Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. With a strong commitment to innovation, quality, and customer satisfaction, we provide reliable healthcare technologies to over 500 healthcare institutions and distributors worldwide.
Our company operates a modern 20,000 sq ft manufacturing facility equipped with advanced production and testing systems. Certified under ISO 13485 quality management standards, all of our products comply with international medical regulations, with key products receiving FDA 510(k) clearance and CE certification.
Future urine sediment analyzers are moving towards Convolutional Neural Networks (CNN) for automated cell recognition. This reduces human error and enhances the diagnostic "Information Gain" for clinicians.
While dry chemistry remains dominant for rapid screening (leukocytes, nitrites, protein), new hybrid systems are emerging that combine traditional strips with microfluidic technology for absolute quantification.
Modern suppliers now provide "Digital Health" ecosystems where analyzer data is automatically uploaded to HIS (Hospital Information Systems) or personal health apps for longitudinal monitoring.
High-throughput automated systems capable of processing 100+ samples per hour, ensuring efficiency in large-scale hospital environments.
Portable, battery-operated analyzers designed for rural clinics and remote areas where infrastructure is limited.
Specialized algorithms for feline and canine urine profiles, catering to the growing global pet healthcare market.
Specific gravity and pH monitoring for professional athletes to ensure hydration levels and biological passport compliance.
Supported by a professional R&D and engineering team, we continuously improve our technologies and provide flexible OEM and ODM solutions tailored to customer needs.
We don't just sell devices; we provide comprehensive healthcare ecosystems. By integrating urine analysis with glucose monitoring and cardiac emergency response (AED), we offer a holistic approach to patient safety.
Centralized data management for multi-department monitoring, ensuring all urine analysis results are synced with patient electronic health records (EHR).
Comprehensive OEM/ODM support, localized marketing materials, and regulatory documentation (FDA/CE) to accelerate market entry.
A: Our systems typically cover 11-14 parameters including Glucose, Bilirubin, Ketone, Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, Leukocytes, and Ascorbic Acid.
A: Expertise is demonstrated through our R&D team; Authoritativeness via ISO 13485 and FDA certifications; and Trustworthiness through our decade-long track record with 500+ institutions.
A: Yes, our portable units are widely used by veterinary clinics for rapid diagnostics in pets and livestock, featuring adjusted reference ranges for different species.
A: Digital analyzers require minimal maintenance compared to manual microscopy. Regular calibration with standard strips and basic cleaning of the optical sensor are sufficient for consistent performance.
